Cosmeceutical Pioneer Strivectin’s ‘Anti-Aging Solutions’ Draw Drug Claim Warning
This article was originally published in The Tan Sheet
Executive Summary
FDA cites Strivectin’s Potent Wrinkle Reducing Treatment and TL Advanced Tightening Neck Cream as unapproved drugs based on claims touting elastin-stimulating effects, skin-firming action and other structure/function benefits.
You may also be interested in...
StriVectin Revises Ad With ‘Clear And Conspicuous’ Disclosure
The National Advertising Division, reflecting FTC enforcement in 2014 on inadequate disclosures, scrutinized print advertising for StriVectin Intensive Illuminating Serum. The skin care firm will revise the ad to address NAD’s concerns about the disclaimer’s placement, clarity and conspicuousness.
StriVectin Revises Ad With ‘Clear And Conspicuous’ Disclosure
The National Advertising Division, reflecting FTC enforcement in 2014 on inadequate disclosures, scrutinized print advertising for StriVectin Intensive Illuminating Serum. The skin care firm will revise the ad to address NAD’s concerns about the disclaimer’s placement, clarity and conspicuousness.
FDA Shows Skin Authority Who’s Boss In Warning For Drug Claims
Another skin care marketer, Skin Authority, receives an FDA warning letter for excessive product claims making its offerings drugs. The agency cites statements touting the firm’s ingredient benefits, including collagen production, improved circulation, inflammation relief and hyperpigmentation treatment, consistent with recent warnings issued to other cosmetics firms.